Positive impactIPO
Jio Platforms Vs Paras Healthcare IPO GMP Today: Who Has Higher Listing Gain Potential?
NDTV Profit 2 hrs ago·27 Oct 2026, 2:32 am
Jio Platforms and Paras Healthcare are two major IPOs currently in the market, drawing significant investor attention. Jio Platforms, backed by Reliance Industries, is a massive issue valued at over Rs 30,000 crore, while Paras Healthcare is a smaller healthcare-focused company. Both are seeing strong demand, with Jio Platforms subscribed 12.45 times and Paras Healthcare subscribed 4.5 times, indicating high interest from retail and institutional investors.
For investors, the key focus is on the Grey Market Premium (GMP), which reflects the expected listing gains. A higher GMP suggests the stock may list at a premium to its issue price. Investors should compare the GMP of both companies to gauge which IPO has better listing potential. However, GMP is not guaranteed, and actual listing prices depend on market conditions on the day of the IPO closure.
What to watch next is the final GMP trends and the overall market sentiment. If the market remains bullish, both stocks could see listing gains. Conversely, a weak market could dampen the premium. Investors should also check the allotment status and keep an eye on the subscription numbers for the remaining days to make informed decisions.
Key takeaways
- Category: IPO.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
